Source: Annual Congress 2005 - Pneumonia in childhood: new perspectives
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Escribano, L. Garcia-Maset, D. Navarro, C. Gimeno, J. Garcia-de-Lomas, and The Spanish Pneumococcal Infection Study Network (Valencia, Spain). Nasopharyngeal carriage of Streptococcus pneumoniae by children with underlying pulmonary diseases. Eur Respir J 2005; 26: Suppl. 49, 1090

Member's Comments

No comment yet.

Related content which might interest you: Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseases Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Pulmonary disease as a risk factor for community-acquired pneumonia caused by multiple pathogens, including Streptococcus pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 502s Year: 2001 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001 Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection Source: Eur Respir J 2004; 24: Suppl. 48, 391s Year: 2004 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Prevalence of S. pneumoniae colonization and serotypes in sputum of vaccine-naive adults with cystic fibrosis. Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Resistance of respiratory tract Streptococcus pneumoniae strains Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002 Chlamydia pneumoniae in children with chronic and recurrent bronchopulmonary diseases Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001